Cancer Therapeutics Companies and Organizations

 

125 Organization(s)

4SC

Business Area(s): 
Description: 
Autoimmune & Cancer Small Molecules

Adaptimmune

Business Area(s): 
Description: 

Revolutionizing cancer therapy on a global basis by developing TCR therapies with the potential to treat a wide range of cancer types and patients.

Adheren

Business Area(s): 
Description: 

Cancer immunotherapy

Aduro Biotech

Business Area(s): 
Description: 

Aduro’s three proprietary technology platforms (Live, Attenuated Double-Deleted Listeria (LADD), STING Pathway Activators, and B-select monoclonal antibodies) have the potential to transform the ...

Advaxis

Business Area(s): 
Description: 

Advaxis’ Lm Technology uses live, attenuated bioengineered Listeria monocytogenes (Lm) bacteria to stimulate the immune system to view tumor cells as potentially ...

Agenus

Business Area(s): 
Description: 

Agenus uses the power of the immune system to develop innovative product candidates against cancer.  The company has assembled a broad portfolio of antibodies including checkpoint inhibitors and ...

Alpine Immune Sciences

Business Area(s): 
Description: 

The company creates protein-based immunotherapies to treat cancer, autoimmune disorders, and other diseases.

Amgen

Business Area(s): 
Description: 

Biologics.  Amgen makes several therapeutic drugs that target serious disease.  Many are derived from engineered monoclonal antibodies.  Some target immune receptors.

Aminex Therapeutics

Business Area(s): 
Description: 

Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint ...

APO-T

Business Area(s): 
Description: 
Antibody Drug Conjugates for cancer

ApoGen Biotech

Business Area(s): 
Description: 

Aptevo Therapeutics

Business Area(s): 
Description: 

Uses modified antibodies to generate immunotherapeutics.

Aravive Biologics

Business Area(s): 
Description: 

Developing novel cancer therapeutics designed to spare healthy cells while targeting tumor adaptive responses and cancer evasion pathways.

Arcus Bioscience

Business Area(s): 
Description: 

Arcus’s lead program targets the adenosine pathway, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.

ARIZ Biopharma

Business Area(s): 
Description: 

Developing PRDM Gene and Protein Modulation Agents as Anti-Cancer Products

Artios Pharma

Business Area(s): 
Description: 

Artios develops cancer treatments that target DNA Damage Response (DDR) pathways in order to selectively kill cancer cells.

Atara Biotherapeutics

Business Area(s): 
Description: 

Atara Bio’s programs include T-cell product candidates and molecularly-targeted product candidates.

Atossa Genetics

Business Area(s): 
Description: 

Atossa Genetics is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.

Avalon GloboCare

Business Area(s): 
Description: 

Avalon GloboCare Corp. is a  healthcare management provider and biotechnology developer, dedicated to integrating and managing global healthcare resources, empowering high-impact biomedical ...

Avergen

Business Area(s): 
Description: 

Avergen is developing a drug discovery platform for identifying highly potent drugs for cancer treatment.

AVM Biotechnology

Business Area(s): 
Description: 

Stem Cell Technologies, Fully Human Biologics Manufacturing Cell Lines, Regenerative Medicine, CAR-T Immunotherapy & Cancer Treatment.

BeiGene

Business Area(s): 
Description: 

A biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer.

Bellicum Pharmaceuticals

Business Area(s): 
Description: 

Develops next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), CAR T cell therapy, and TCR ...

Besins Healthcare

Business Area(s): 
Description: 

Besins Healthcare produces anti-cancer drugs, and hormone therapies.

Bicycle Therapeutics

Business Area(s): 
Description: 

Bicycles are a new therapeutic modality combining the attributes of antibodies, small molecules and peptides within one molecule. Bicycles exhibit the affinity and selective ...

bioAffinity Technologies

Business Area(s): 
Description: 

bioAffinity Technologies, Inc. develops tests and therapies to detect and treat cancer at the cellular level with porphyrin molecules. 

Biokine Therapeutics

Business Area(s): 
Description: 
Novel molecular and cellular mechanisms that regulate tumor development and metastasis

Biolyse Pharma

Business Area(s): 
Description: 

Biolyse Pharma specializes in manufacturing and developing of sterile oncology drugs.

- Currently produces Paclitaxel for the treatment of cancer, known for its mild side effects when ...

Blaze Bioscience

Business Area(s): 
Description: 

Real-time cancer cell visualization for surgical applications. Blaze is working to develop Tumor Paint products and Optide*-based guided therapeutics.

Bluebird Bio

Business Area(s): 
Description: 

The cancer immunotherapy research group is focused on the next generation of T cell engineering and creating a pipeline of T cell product candidates (CAR T cells) to treat a wide variety of liquid ...

Bristol-Myers Squibb

Business Area(s): 
Description: 

A biopharmaceutical company.  They discover, develop, and deliver medicines to treat serious disease.

Cascadian Therapeutics

Business Area(s): 
Description: 

Develops novel compounds for cancer treatment. The most advanced product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor. 

CellAct Pharma GmbH

Business Area(s): 
Description: 

CellAct Pharma GmbH was founded by Fritz Kopitzki and Nalân Utku in 2007 as a venture backed biotech company. CellAct is focused on the development of innovative therapeutics for the treatment of ...

Celldex Therapeutics

Business Area(s): 
Description: 

Small Molecules, Biologics, Vaccines, The pipeline is comprised of antibody-based therapies and other protein-based therapeutics that modulate the immune system or directly target tumors.

Cellectis

Business Area(s): 
Description: 

Designing next generation immunotherapies based on gene-edited CAR T-cells

CellPly

Business Area(s): 
Description: 
Personalized cancer treatment

Checkmate Pharma

Business Area(s): 
Description: 

Develops technology to activate the innate and adaptive arms of the immune system to recognize and ultimately destroy tumor cells.

Christiana Care

Business Area(s): 
Description: 

A private, non-profit, regional health care system.

CisThera

Business Area(s): 
Description: 

CisThera’s mission is to develop innovative therapeutics to treat  cancer, autoimmune diseases, as well as chronic kidney and liver diseases.

Clanotech

Business Area(s): 
Description: 
Anti-angiogenic compounds for cancer & AMD

Cleveland Biolabs

Business Area(s): 
Description: 

Develops molecules to activate Toll like receptors.  These can be used to stimulate the innate immune system.  

Codiak Biosciences

Business Area(s): 
Description: 

Codiak plans to define and engineer exosomes with single or multiple payloads directed against specific intracellular targets.

Compliment Corporation

Business Area(s): 
Description: 

Compliment Corporation is a start-up biotechnology company developing revolutionary therapeutics in oncology.  Our mission is to improve cancer treatment by dramatically increasing the ...

Corvus Pharmaceuticals

Business Area(s): 
Description: 

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel agents that target the immune system to treat patients with cancer. 

CTI BioPharma

Business Area(s): 
Description: 

CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers

Cullinan Oncology

Business Area(s): 
Description: 

Cullinan Oncology develops high value therapeutics geared towards dramatically improving the standard of care for those living with cancer.

Curis

Business Area(s): 
Description: 

Develops anti-cancer drugs.

Cytimmune

Business Area(s): 
Description: 

CytImmune’s nanotherapy platform, Aurimune, is a tumor-targeted Trojan horse. Aurimune selectively binds TNF receptors on blood vessel cells at the site of disease. Once bound, Aurimune unleashes ...

CytomX Therapeutics

Business Area(s): 
Description: 

Develops cancer immunotherapies, drug conjugates (PDCs), T-cell engaging Probody bispecifics and ProCAR-NK cell therapies based on Protease-Activated Antibodies, 'Probodies'

Dendreon

Business Area(s): 
Description: 

Immunotherapy treatment for prostate cancer.

FivePrime

Business Area(s): 
Description: 

Focused on therapies for cancer and inflammatory diseases

FLX Bio

Business Area(s): 
Description: 

Activating the immune system to eradicate cancer.  Focuses on regulatory T cells.

Forty Seven

Business Area(s): 
Description: 

Committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.

Ganymed Pharmaceuticals

Business Area(s): 
Description: 
Monoclonal antibodies targeting cancer

Geneius Biotechnology

Business Area(s): 
Description: 

Immuno-oncology targeting

Gilead

Business Area(s): 
Description: 

Research and development programs currently focus on potential treatments in HIV/AIDS, liver diseases, hematology and oncology, inflammatory and respiratory diseases, and cardiovascular conditions ...

Gradalis

Business Area(s): 
Description: 

Cancer immunotherapy.  

Green Cross Cell

Business Area(s): 
Description: 

Develops anti-cancer immunotherapies

Grid Therapeutics

Business Area(s): 
Description: 

Grid Therapeutics is an emerging biotechnology company located in Durham, North Carolina. Grid’s research and development efforts are in the area of cancer therapeutics, applying an innovative ...

Don't see an employer? Please fill out the form